AJRCCM: 100-YearAnniversary.Progress along the Pathway of Discovery Leading to Treatment and Cure of Cystic Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

AJRCCM: 100-YearAnniversary.Progress along the Pathway of Discovery Leading to Treatment and Cure of Cystic Fibrosis

Published:2017-05 Issue:9 Volume:195 Page:1092-1099
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Ramsey Bonnie W.¹²^ORCID,Welsh Michael J.³⁴⁵^ORCID

Affiliation:

1. Department of PediatricsUniversity of Washington School of MedicineSeattle, Washington

2. Center for Clinical and Translational ResearchSeattle Children’s Research InstituteSeattle, Washington

3. Pappajohn Biomedical Institute

4. Howard Hughes Medical Instituteand

5. Roy J. and Lucille A. Carver College of MedicineUniversity of IowaIowa City, Iowa

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

http://www.atsjournals.org/doi/pdf/10.1164/rccm.201702-0266ED

Reference77 articles.

1. CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE

2. Chloride impermeability in cystic fibrosis

3. Abnormal Ion Permeation Through Cystic Fibrosis Respiratory Epithelium

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A model for oversight of rare disease studies: The 25-year experience of the cystic fibrosis foundation data safety monitoring board;Journal of Cystic Fibrosis;2024-07

2. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Targeted Therapeutics for Cystic Fibrosis;Ion Channels as Targets in Drug Discovery;2024

3. Loss of CFTR function in macrophages alters the cell transcriptional program and delays lung resolution of inflammation;Frontiers in Immunology;2023-11-16

4. Aberrant immune programming in neutrophils in cystic fibrosis;Journal of Leukocyte Biology;2023-11-06

5. Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years;Frontiers in Pharmacology;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3